{"title":"甲状腺毒症和甲状腺毒性周期性麻痹的20年趋势:一项基于人群的队列研究。","authors":"Gloria Hoi-Yee Li, Ching-Man Tang, Ray Shing-Hin Li, Grace Mengqin Ge, Annie Wai-Chee Kung, Kathryn Choon-Beng Tan, Elaine Yun-Ning Cheung, Ching-Lung Cheung","doi":"10.1530/ETJ-25-0220","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Thyrotoxic periodic paralysis (TPP) is a rare but potentially lethal complication of thyrotoxicosis. Absence of large cohorts limits the conduct of epidemiology studies. We aimed to establish a population-based registry of thyrotoxicosis and TPP in Hong Kong and evaluate their trend.</p><p><strong>Methods: </strong>We developed algorithms to identify thyrotoxicosis and TPP cases from a representative electronic medical database in Hong Kong. Of the potential cases (thyrotoxicosis:83,184; TPP:999), we reviewed clinical notes and laboratory test records of 200 randomly selected cases. Population-based registries of thyrotoxicosis and TPP were subsequently established. Their standardized incidence rate, TPP-associated hospitalization rate, length of stay (LOS), and trends from 2002 to 2021 were evaluated.</p><p><strong>Results: </strong>Positive predictive values for thyrotoxicosis and TPP were 0.86-0.97, respectively, enabling establishment of population-based cohorts of incident thyrotoxicosis (n = 77,856) and TPP (n = 994). Age- and sex-standardized incidence rate (per 100,000 person-years) of thyrotoxicosis increased from 41.31 in 2002 to 69.51 in 2021 (average annual percentage change: 4.77%), with a similar trend observed in both sexes. TPP patients were predominantly male (93.66%). In 2002 and 2021, the age-standardized incidence rate (per 100,000 person-years) of TPP in males was 1.43 and 1.18, respectively, while that in females was 0.11 and 0.13, without a significant trend observed. TPP-associated hospitalization rate (90.91-100%) and median LOS (2-3 days) were steady across the two decades.</p><p><strong>Conclusion: </strong>This is the first study establishing a TPP cohort based on validated clinical data from an electronic medical database. It is important to keep monitoring the increasing incidence rate of thyrotoxicosis.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478295/pdf/","citationCount":"0","resultStr":"{\"title\":\"Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.\",\"authors\":\"Gloria Hoi-Yee Li, Ching-Man Tang, Ray Shing-Hin Li, Grace Mengqin Ge, Annie Wai-Chee Kung, Kathryn Choon-Beng Tan, Elaine Yun-Ning Cheung, Ching-Lung Cheung\",\"doi\":\"10.1530/ETJ-25-0220\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Thyrotoxic periodic paralysis (TPP) is a rare but potentially lethal complication of thyrotoxicosis. Absence of large cohorts limits the conduct of epidemiology studies. We aimed to establish a population-based registry of thyrotoxicosis and TPP in Hong Kong and evaluate their trend.</p><p><strong>Methods: </strong>We developed algorithms to identify thyrotoxicosis and TPP cases from a representative electronic medical database in Hong Kong. Of the potential cases (thyrotoxicosis:83,184; TPP:999), we reviewed clinical notes and laboratory test records of 200 randomly selected cases. Population-based registries of thyrotoxicosis and TPP were subsequently established. Their standardized incidence rate, TPP-associated hospitalization rate, length of stay (LOS), and trends from 2002 to 2021 were evaluated.</p><p><strong>Results: </strong>Positive predictive values for thyrotoxicosis and TPP were 0.86-0.97, respectively, enabling establishment of population-based cohorts of incident thyrotoxicosis (n = 77,856) and TPP (n = 994). Age- and sex-standardized incidence rate (per 100,000 person-years) of thyrotoxicosis increased from 41.31 in 2002 to 69.51 in 2021 (average annual percentage change: 4.77%), with a similar trend observed in both sexes. TPP patients were predominantly male (93.66%). In 2002 and 2021, the age-standardized incidence rate (per 100,000 person-years) of TPP in males was 1.43 and 1.18, respectively, while that in females was 0.11 and 0.13, without a significant trend observed. TPP-associated hospitalization rate (90.91-100%) and median LOS (2-3 days) were steady across the two decades.</p><p><strong>Conclusion: </strong>This is the first study establishing a TPP cohort based on validated clinical data from an electronic medical database. It is important to keep monitoring the increasing incidence rate of thyrotoxicosis.</p>\",\"PeriodicalId\":12159,\"journal\":{\"name\":\"European Thyroid Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478295/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Thyroid Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1530/ETJ-25-0220\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/10/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Thyroid Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ETJ-25-0220","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.
Objective: Thyrotoxic periodic paralysis (TPP) is a rare but potentially lethal complication of thyrotoxicosis. Absence of large cohorts limits the conduct of epidemiology studies. We aimed to establish a population-based registry of thyrotoxicosis and TPP in Hong Kong and evaluate their trend.
Methods: We developed algorithms to identify thyrotoxicosis and TPP cases from a representative electronic medical database in Hong Kong. Of the potential cases (thyrotoxicosis:83,184; TPP:999), we reviewed clinical notes and laboratory test records of 200 randomly selected cases. Population-based registries of thyrotoxicosis and TPP were subsequently established. Their standardized incidence rate, TPP-associated hospitalization rate, length of stay (LOS), and trends from 2002 to 2021 were evaluated.
Results: Positive predictive values for thyrotoxicosis and TPP were 0.86-0.97, respectively, enabling establishment of population-based cohorts of incident thyrotoxicosis (n = 77,856) and TPP (n = 994). Age- and sex-standardized incidence rate (per 100,000 person-years) of thyrotoxicosis increased from 41.31 in 2002 to 69.51 in 2021 (average annual percentage change: 4.77%), with a similar trend observed in both sexes. TPP patients were predominantly male (93.66%). In 2002 and 2021, the age-standardized incidence rate (per 100,000 person-years) of TPP in males was 1.43 and 1.18, respectively, while that in females was 0.11 and 0.13, without a significant trend observed. TPP-associated hospitalization rate (90.91-100%) and median LOS (2-3 days) were steady across the two decades.
Conclusion: This is the first study establishing a TPP cohort based on validated clinical data from an electronic medical database. It is important to keep monitoring the increasing incidence rate of thyrotoxicosis.
期刊介绍:
The ''European Thyroid Journal'' publishes papers reporting original research in basic, translational and clinical thyroidology. Original contributions cover all aspects of the field, from molecular and cellular biology to immunology and biochemistry, from physiology to pathology, and from pediatric to adult thyroid diseases with a special focus on thyroid cancer. Readers also benefit from reviews by noted experts, which highlight especially active areas of current research. The journal will further publish formal guidelines in the field, produced and endorsed by the European Thyroid Association.